Aarti Industries demerger: All you need to know

Aarti Industries in August last year announced a demerger plan, thereby separating its specialty chemicals business (to operate under Aarti Industries Limited – AIL) and its pharma business (Aarti Pharmalabs Limited – APL). The company had fixed October 20, 2022, as the record date for the demerger.

According to the demerger plan, shareholders will get one share of Aarti Pharmalabs for every four shares they hold in Aarti Industries.

According to the company, the strategic decision of demerger was taken with the rationale of achieving operational efficiencies by streamlining the businesses.

"Record Date: Thursday, October 20, 2022 — To determine the members of 'Aarti Industries Limited' (as per the scheme Demerged Company), to whom Equity Shares of 'Aarti Pharmalabs Limited' (as per the scheme Resulting Company) to be allotted pursuant to part 'B' under Paragraph 13.1 of the Scheme," Aarti Industries informed exchanges about the demerger record date.

Aarti Industries will primarily focus on manufacturing specialty chemicals while Aarti Pharmalabs will focus on skin care products, steroids, and drugs.

The company has plans to strengthen its manufacturing capability by adding over 50 new products in the pharma division with a Capex of Rs 350-500 crore in three years.

Aarti Industries shares are one of the multibagger stocks. The chemical stock has doubled investors' money in the last two. In 5 years, it has delivered a whopping 275 per cent returns.